NO913129L - Nytt trombolytisk middel. - Google Patents

Nytt trombolytisk middel.

Info

Publication number
NO913129L
NO913129L NO91913129A NO913129A NO913129L NO 913129 L NO913129 L NO 913129L NO 91913129 A NO91913129 A NO 91913129A NO 913129 A NO913129 A NO 913129A NO 913129 L NO913129 L NO 913129L
Authority
NO
Norway
Prior art keywords
trombolytic
agent
new
thrombolitic
novel
Prior art date
Application number
NO91913129A
Other languages
English (en)
Other versions
NO308708B1 (no
NO913129D0 (no
Inventor
Berthold Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO913129D0 publication Critical patent/NO913129D0/no
Publication of NO913129L publication Critical patent/NO913129L/no
Publication of NO308708B1 publication Critical patent/NO308708B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO913129A 1989-02-13 1991-08-12 FremgangsmÕte for fremstilling av et trombolytisk protein, samt isolert DNA, mikroorganisme og fremgangsmÕte for fremstilling av et farmasøytisk preparat NO308708B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum
PCT/EP1990/000242 WO1990009438A1 (en) 1989-02-13 1990-02-13 Novel thrombolytic

Publications (3)

Publication Number Publication Date
NO913129D0 NO913129D0 (no) 1991-08-12
NO913129L true NO913129L (no) 1991-10-11
NO308708B1 NO308708B1 (no) 2000-10-16

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913129A NO308708B1 (no) 1989-02-13 1991-08-12 FremgangsmÕte for fremstilling av et trombolytisk protein, samt isolert DNA, mikroorganisme og fremgangsmÕte for fremstilling av et farmasøytisk preparat

Country Status (16)

Country Link
EP (1) EP0383417B1 (no)
JP (1) JP2904918B2 (no)
AT (1) ATE132187T1 (no)
AU (1) AU642404B2 (no)
BR (1) BR9007115A (no)
CA (1) CA2046632C (no)
DE (1) DE69024382T2 (no)
DK (1) DK0383417T3 (no)
ES (1) ES2085326T3 (no)
FI (1) FI103577B (no)
GR (1) GR3019328T3 (no)
HU (1) HU217219B (no)
IE (1) IE73229B1 (no)
NO (1) NO308708B1 (no)
UA (1) UA34415C2 (no)
WO (1) WO1990009438A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
CA2522989A1 (en) * 2003-05-21 2004-12-02 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
WO2007134617A1 (en) * 2006-05-19 2007-11-29 Paion Deutschland Gmbh Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
RU2009122514A (ru) 2006-11-17 2010-12-27 Новартис АГ (CH) Молекулы, связывающие белок lingo, и их фармацевтическое применение
AU2008317724B2 (en) 2007-11-02 2011-06-02 Novartis Ag Improved Nogo-A binding molecules and pharmaceutical use thereof
WO2011107299A2 (en) 2010-04-16 2011-09-09 Paion Deutschland Gmbh Method for the manufacture of recombinant dspa alpha1
WO2021079002A2 (en) 2019-10-24 2021-04-29 Novago Therapeutics Ag Novel anti-nogo-a antibodies
WO2026041734A1 (en) 2024-08-22 2026-02-26 Novago Therapeutics Ag Methods for treating neurological disorders using anti-nogo-a antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer

Also Published As

Publication number Publication date
FI103577B1 (fi) 1999-07-30
DE69024382T2 (de) 1996-08-14
WO1990009438A1 (en) 1990-08-23
FI103577B (fi) 1999-07-30
DE69024382D1 (de) 1996-02-08
NO308708B1 (no) 2000-10-16
ES2085326T3 (es) 1996-06-01
BR9007115A (pt) 1991-11-26
AU642404B2 (en) 1993-10-21
EP0383417A1 (en) 1990-08-22
JPH04504799A (ja) 1992-08-27
DK0383417T3 (da) 1996-05-13
CA2046632A1 (en) 1990-08-14
HU902004D0 (en) 1991-11-28
HUT59724A (en) 1992-06-29
FI913818A0 (fi) 1991-08-12
JP2904918B2 (ja) 1999-06-14
EP0383417B1 (en) 1995-12-27
AU5080790A (en) 1990-09-05
CA2046632C (en) 1999-05-11
IE73229B1 (en) 1997-05-21
NO913129D0 (no) 1991-08-12
ATE132187T1 (de) 1996-01-15
GR3019328T3 (en) 1996-06-30
HU217219B (hu) 1999-12-28
IE900506L (en) 1990-08-13
UA34415C2 (uk) 2001-03-15

Similar Documents

Publication Publication Date Title
NO913129D0 (no) Nytt trombolytisk middel.
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DK31088A (da) Blodkoaguleringsnedsaettende peptidderivater
DK90089A (da) Hudbehandlingspraeparat
EP0376251A3 (en) An anticoagulant substance obtained from urine
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
IT216694Z2 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
DE3771266D1 (de) Medizinisches instrument zum ausschneiden von knochengewebe.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
RU93035257A (ru) Способ лечения болезни пайра
ATE65394T1 (de) Behandlung von knochenschwund.
IT8609534A0 (it) Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.
IT8722734A0 (it) Apparecchiatura per la rigenerazione e depurazione del sangue.
DE3771706D1 (de) Behandlung von knochenschwund.

Legal Events

Date Code Title Description
MK1K Patent expired